Myriad Genetics Sponsors Dance-Theater Event Hosted By Alzheimer's Association, New York City Chapter
Posted on: Tuesday, 30 October 2007, 06:00 CDT
Myriad Genetics, Inc. (NASDAQ: MYGN) (www.myriad.com) announced today that it is sponsoring a unique dance-theater event titled, "Demolition Derby: when a mind loses its license to drive," hosted by the Alzheimer's Association, New York City Chapter on November 2, 2007.
The event is created by Erik Stern and portrays a son's experience caring for his parents who have dementia. There will be a panel discussion following the performance, with an opportunity for audience members to ask questions of Alzheimer's disease experts, patient advocates and Mr. Stern.
"We are very pleased to sponsor this powerful, engaging event," said Adrian Hobden, Ph.D., President of Myriad Pharmaceuticals, Inc. "Dance provides a fascinating method of exploring the challenges for patients and their caregivers in dealing with the multitude of changes brought on by Alzheimer's disease."
"Caring for a loved one with Alzheimer's is demanding, exhausting and can negatively impact a person's health and well being," said Lou-Ellen Barkan, president and CEO of the Alzheimer's Association, New York City Chapter. "Often, caregivers suffer these consequences in silence and alone. I want to thank Erik Stern not only for his talent, but for sharing a deeply personal part of his life with us. I know this piece will resonate with everyone who sees it."
The New York City performance will be held at 6:30 p.m. at the Gerald W. Lynch Theater at John Jay College, 899 Tenth Avenue, between 58th and 59th Streets. Tickets are available through www.ticketweb.com, or by phone at (866) 468-7619. All proceeds go to the Alzheimer's Association, New York City Chapter.
Myriad Pharmaceuticals, Inc. is a subsidiary of Myriad Genetics, Inc., a biotechnology company focused on the development and marketing of novel therapeutic and molecular diagnostic products. The Company's lead drug candidate is Flurizan(TM), in clinical development for the treatment of Alzheimer's disease. Myriad's news and other information are available on the Company's Web site at www.myriad.com.
Contacts: Myriad Genetics William A. Hockett EVP, Corporate Communications (801) 584-3600 Email: Email Contact For the Alzheimer's Association, New York City Chapter: Kim Esp/Colleen Roche Linden Alschuler & Kaplan Public Relations 212-575-4545 Email Contact
SOURCE: Myriad Genetics
Source: MARKET WIRE
Related Articles
- New York City Off-Track Betting Corp. To Begin Restructuring Process Through Chapter 9 Filing
- EMRG Media Launches New York City Business Networking Series
- EHE International Helps Alzheimer's Association, New York City Chapter to Raise Awareness About Alzheimer's Disease
- EMRG Media, LLC Has the Inside Scoop on New York City Event and Party Planning Venues
- DKMS and The Leukemia &Amp; Lymphoma Society's New York City Chapter Announce Partnership
- Applied NeuroSolutions' Founding Scientist, Dr. Peter Davies, to Participate on Panel at Alzheimer's Association New York City Chapter's 20th Annual Meeting
- Drug Store News Hosts the 2nd Annual Caregiver Expo in New York City at the Penn Plaza Pavilion
- MTV Takes Over New York City With Vma Events, Concerts, Promotions And More Leading Up to the 2006 Video Music Awards On August 31st at 8 PM ET/PT
- Interep Announces Third Annual Radio Symposium 'Radio 101: Back to the Basics, Off to the Future' to Be Held June 28th in New York City
 |
 |
User Comments (0)
RSS Feeds